drugset / Trial / NCT00002675

Chemotherapy in Treating Patients With Retinoblastoma

NCT00002675

Phase 2 Completed 50 enrolled Memorial Sloan Kettering Cancer Center
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with retinoblastoma.

Timeline

Start
1995-05
Primary completion
2001-01
Completion
2001-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule Intravenous
Subject Cisplatin Other / unclassified Intravenous
Subject Cyclophosphamide Other / unclassified Intravenous
Subject Etoposide Small molecule Intravenous
Subject Vincristine Small molecule Intravenous
Background 2-MERCAPTOETHANESULFONIC ACID Small molecule
Background filgrastim Protein / enzyme biologic Subcutaneous